Aayush Wellness announced the launch of its Lung Care Tablets, marking a significant expansion of its prevention led healthcare vision. Building on the proposition of Aayush Herbal Masala, developed around the health concerns associated with smokeless-tobacco consumption, the Company is now extending its focus to respiratory wellness, addressing the growing health challenges associated with smoking, air pollution and environmental exposure.

The launch comes at a time when India's respiratory healthcare segment represents a significant and growing market. The Respiratory System therapeutic segment recorded sales of Rs 18,912.64 crore in 2025, up from Rs 17,199.40 crore in 2024, representing approximately 10% YoY growth. With India accounting for 30.28% of global deaths from respiratory diseases, Aayush Wellness sees an opportunity to build a differentiated position in the emerging preventive respiratory-wellness category.